NCT00158223 Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Status COMPLETED Phase PHASE4
NCT00156715 Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder Status COMPLETED Phase PHASE4
NCT00156117 Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) Status COMPLETED Phase PHASE3
NCT00156104 Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00156091 Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) Status COMPLETED Phase PHASE3
NCT00156065 Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) Status COMPLETED Phase PHASE3
NCT00155818 Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia Status COMPLETED Phase N/A
NCT00155701 Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia Status COMPLETED Phase N/A
NCT00155519 A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions Status COMPLETED Phase N/A
NCT00155506 Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios Status COMPLETED Phase N/A
NCT00155207 A Study on Risk Mutations of Vulnerability Genes of Schizophrenia Status UNKNOWN Phase N/A
NCT00154258 A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia Status COMPLETED Phase PHASE2
NCT00151424 Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) Status COMPLETED Phase PHASE3
NCT00150215 A First In Human Study Of PF-00184562 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00150176 To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) Status COMPLETED Phase PHASE3
NCT00149734 Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia Status COMPLETED Phase PHASE3